These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25896556)
21. Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora. Eruz ED; Yalci A; Ozden E; Aslaner H; Ogucu-Durgun S; Koseoglu-Taymur DD; Memikoglu KO; Erdem H; Kurt H J Infect Dev Ctries; 2017 Feb; 11(2):188-191. PubMed ID: 28248681 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study. Hwang EC; Jung SI; Seo YH; Jeong SH; Kwon DD; Park K; Kim JW Int Urol Nephrol; 2015 Apr; 47(4):595-601. PubMed ID: 25712677 [TBL] [Abstract][Full Text] [Related]
24. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization. Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial. Salomon G; Saul J; Prues S; Schneider M; Budäus L; Tilki D; Rohde H; Haferkamp A; Graefen M; Boehm K World J Urol; 2018 Jun; 36(6):871-876. PubMed ID: 29417288 [TBL] [Abstract][Full Text] [Related]
26. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study. Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042 [TBL] [Abstract][Full Text] [Related]
28. Prevention of infectious complications after prostate biopsy procedure. Togo Y; Yamamoto S Int J Urol; 2017 Jul; 24(7):486-492. PubMed ID: 28556409 [TBL] [Abstract][Full Text] [Related]
29. Preventing Prostate Biopsy Complications: to Augment or to Swab? Glick L; Vincent SA; Squadron D; Han TM; Syed K; Danella JF; Ginzburg S; Guzzo TJ; Lanchoney T; Raman JD; Smaldone M; Uzzo RG; Tomaszweski JJ; Reese A; Singer EA; Jacobs B; Trabulsi EJ; Gomella LG; Mann MJ Urology; 2021 Sep; 155():12-19. PubMed ID: 33878333 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354 [TBL] [Abstract][Full Text] [Related]
32. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study. Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680 [TBL] [Abstract][Full Text] [Related]
33. Utilizing a Questionnaire to Implement a Risk-based Antibiotic Prophylaxis Protocol for Transrectal Prostate Biopsy. Gul ZG; Yu M; Sharbaugh DR; Pekala KR; Lin JY; Sharbaugh AJ; Zhu TS; Worku H; Armann KM; Hudson CN; Hay JM; Grajales V; Yabes JG; Davies BJ; Jacobs BL Urology; 2023 May; 175():18-24. PubMed ID: 36868411 [TBL] [Abstract][Full Text] [Related]
34. [Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination]. Wang H; Zhou X; Chen S; Zhu C; Yu X Zhonghua Nan Ke Xue; 2004 Jul; 10(7):496-8, 502. PubMed ID: 15354517 [TBL] [Abstract][Full Text] [Related]
35. Optimal Antibiotic Use to Prevent Post-Prostate Biopsy Infection. Jones JS J Urol; 2015 Aug; 194(2):282-3. PubMed ID: 25986517 [No Abstract] [Full Text] [Related]
37. Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy. Recabal P; Lee T; Vertosick E; Manasia M; Eastham J; Touijer K; Seo SK; Spaliviero M; Ehdaie B World J Urol; 2020 Apr; 38(4):965-970. PubMed ID: 31190154 [TBL] [Abstract][Full Text] [Related]
38. Impact of Rectal Swabs on Infectious Complications after Transrectal Prostate Biopsy. Trujillo CG; Plata M; Caicedo JI; Cataño Cataño JG; Mariño Alvarez AM; Castelblanco D; Robledo D Urol Int; 2016; 97(3):340-346. PubMed ID: 27694748 [TBL] [Abstract][Full Text] [Related]
39. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study. Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451 [TBL] [Abstract][Full Text] [Related]